Myotonia Congenita

This is a specific type of myotonia that people are born with. It causes muscles to stay tight or stiff. It can make it hard to move normally, like walking. There are different kinds, depending on how it runs in the family.

Condition

What people with Myotonia Congenita report

Every report comes from a Lived member, sent anonymously.

Have you tried Acetazolamide for Myotonia Congenita?

NameHow it went

About Myotonia Congenita

What It Is

Myotonia congenita is an inherited muscle condition in which the muscles used for movement are slow to relax after they tighten. The result is stiffness, most often in the legs but sometimes in the hands, face, eyelids or tongue. It is usually worst on the first movements after a period of rest, such as standing up after sitting, taking the first steps or letting go of a firm grip. With repeated movement the stiffness eases, a pattern known as the warm-up effect. Symptoms usually begin in childhood. In some people the stiffness is barely noticeable; in others it is enough to interfere with walking, running and other everyday activities. Many people have well-developed, unusually bulky muscles. Myotonia congenita affects only the skeletal muscles. It is a different condition from myotonic dystrophy, which also causes stiffness but brings progressive weakness and problems with the heart, eyes and other organs.

Causes & Risk Factors

Myotonia congenita is caused by changes (variants) in the CLCN1 gene. This gene carries the instructions for a chloride channel, a pore in the muscle cell membrane that helps each muscle fiber settle back to rest after a signal to contract. When the channel works poorly, the fiber keeps firing after the movement has ended, so the muscle stays tight for longer than it should. There are two inherited forms. In Thomsen disease, one altered copy of the gene is enough to cause symptoms, so it usually passes from an affected parent, and each child of that parent has a 50 percent chance of inheriting it. In Becker disease, a person has inherited an altered copy from each parent. The parents are usually carriers without symptoms, and each of their children has a 25 percent chance of being affected. Becker disease tends to start somewhat later in childhood and is generally more severe, and it can bring brief spells of weakness when moving after rest. Because some gene changes can behave either way, the form is not always obvious from genetics alone. The condition is rare, estimated at about 1 in 100,000 people worldwide, and is more common in northern Scandinavia.

How It's Diagnosed

Diagnosis starts with the history and a physical examination. A clinician looks for muscles that are slow to release after a strong contraction, or that stay briefly tightened after being tapped, and asks how the stiffness behaves after rest and with repeated movement. Electromyography (EMG), a test that records the electrical activity of muscle through a fine needle, typically shows distinctive bursts called myotonic discharges. These support the diagnosis, but they also occur in some other muscle diseases. Genetic testing confirms myotonia congenita by finding a disease-causing variant in the CLCN1 gene, in one or both copies. It is often done as a panel that also checks SCN4A, the gene behind sodium channel myotonias, which can look similar. Blood levels of creatine kinase (CK), an enzyme released by muscle, are usually normal or only mildly raised. Once the variant in a family is known, relatives can be tested, and testing is also possible during a pregnancy or on embryos before implantation during in vitro fertilization.

Treatment Options

No treatment corrects the faulty channel, but stiffness can often be reduced. Not everyone needs medicine: the decision depends on how much the stiffness gets in the way of work, walking, sport or other daily activities. Mexiletine is the medicine with the best evidence. It was developed to treat heart rhythm problems and works by blocking sodium channels, which calms the overexcitable muscle membrane. In trials of people with non-dystrophic myotonias, the group that includes myotonia congenita, it reduced day-to-day stiffness compared with a placebo and may improve quality of life, often working within hours to days. In the United States its labeled use is for serious heart rhythm problems, so prescribing it for myotonia is off-label. Because it can affect heart rhythm, a heart check with an electrocardiogram (ECG) is part of starting and monitoring treatment. Stomach upset is common, and it is usually taken up to three times a day. Lamotrigine (Lamictal), an epilepsy medicine that also blocks sodium channels, is an alternative with smaller trials showing less stiffness and better quality of life. It can take weeks to help, and its main serious risk is a rare but dangerous skin rash. Older sodium channel blockers such as carbamazepine and phenytoin, and acetazolamide, are sometimes used, with less evidence. The mexiletine trials did not include people under 16, so treatment for children relies more on specialist judgment.

What to Expect

Myotonia congenita does not affect the heart or other organs, and life expectancy is normal. Symptoms often stay fairly steady over years, although some people notice gradual worsening, and people with Becker disease can develop mild, lasting weakness over time. Men tend to be more severely affected than women. Day to day, stiffness is most noticeable when starting to move after sitting or lying still. The first steps, climbing stairs or getting up quickly can feel awkward and sometimes lead to falls before the muscles loosen. In Becker disease, a burst of movement after rest can also bring a short spell of weakness, particularly in the arms and hands, that passes as activity continues. The most important practical precaution concerns anesthesia. Some drugs used during surgery, especially the muscle relaxant succinylcholine (also called suxamethonium), can trigger severe muscle spasm that makes breathing support difficult. Surgeons and anesthesia teams need to know about the diagnosis well before any procedure so they can choose safer drugs. This risk is one reason that testing children in an affected family is considered worthwhile. Some everyday medicines, including the beta blocker propranolol and beta-agonist inhalers used for asthma, may also make stiffness worse, so it helps to mention the diagnosis whenever a new medicine is prescribed.

When to Seek Help

Arrange an assessment, ideally with a neurologist or neuromuscular specialist, for muscle stiffness that is worst after rest and eases with movement. In a child, frequent falls, an unusual way of walking, leg cramps, feeding or swallowing difficulty, or eyes that stay squeezed shut after crying are worth raising with the pediatrician. If you already have the diagnosis, contact your care team when stiffness or episodes of weakness begin to limit walking, work or daily activities, when a newly started medicine seems to make stiffness worse, or when a treatment for myotonia causes side effects that make it hard to continue.

Questions to Ask Your Doctor

  1. 1.Do my symptoms and test results point to Thomsen or Becker disease, and what does that mean for my children or other relatives?
  2. 2.Is my stiffness affecting daily life enough that medicine is worth trying, and how will we judge whether it helps?
  3. 3.What heart checks would I need before and during mexiletine, and what are the alternatives if it does not suit me?
  4. 4.How should I tell surgeons and anesthesia teams about my condition, and would carrying written information help?
  5. 5.Are there ways to plan exercise, sport or work around the stiffness that could make a difference for me?

Last reviewed • Oct 2026

Educational content, not medical advice.